Sierra Oncology's Series D Round

Sierra Oncology raised a round of funding on April 21, 2014.

Sierra Oncology, formerly ProNAi Therapeutics, is applying nucleic acid-based DNA interference technology (DNAi) to discover and develop therapeutic approaches for cancer and other diseases. The compa…

Articles about Sierra Oncology's Series D Round: